Patent Antibody Case Law Continues To Mature - Intellectual

Explosive growth of antibody technology and therapeutics over the past three decades has driven development of antibody-centric patent case law across several fronts.

Related Keywords

Delaware , United States , James Evans , Eli Lilly , Idenix Pharms , Glaxosmithkline , Johns Hopkins University , Amgen , Psys Inc , Janssen Biotech Inc , Genentech , Immunex Corp , United States District Court , Hybritech Inc , Patent Office , Ariad Pharm Inc , Wyeth Cordis Corp , Abbvie Deutschland Gmbh Co , Resolution At Regeneron Pharmaceuticals , Juno Therapeutics Inc , Regeneron Pharmaceuticals , See Burroughs Wellcome Co , Enzo Life Scis Inc , Amgen Inc , Centocor Ortho Biotech Inc , Federal Circuit , Patent Trial , Federal Circuit Judge Timothy , Burroughs Wellcome , Carnegie Mellon Univ , Ariad Pharm , Centocor Ortho Biotech , Abbvie Deutschland Gmbh , Janssen Biotech , Juno Therapeutics , Enzo Life Scis , Judge Stark , States Patent , Trade Office , Mondaq , Patent Antibody Case Law Continues To Mature , Food , Drugs , Healthcare , Life Sciences , Iotechnology Amp Nanotechnology , Intellectual Property , Patent , ,